California-based Alten Calsoft Labs has launched a BioPharma Ledger, a Blockchain clinical trial platform.
Paul Elisii, ALTEN Calsoft Labs VP Blockchain:
“The Blockchain for clinical trials is our first initiative in the broader Blockchain practice at ALTEN Calsoft Labs. We will make a significant impact on the clinical trial process with our scalable Blockchain platform that will ultimately address many key core processes in the Life Sciences industry.”
The newly created Blockchain Platform for clinical trials will leverage the BlockApps STRATO middleware platform. BlockApps is a founding member of the Enterprise Ethereum Alliance (EEA), the world’s largest open source blockchain initiative.
Clinlogix, a leading-edge global clinical research organization (CRO), with locations in Europe, Asia, South America and the US will be the first practitioner to pilot and implement the platform in real world clinical trials.
JeanMarie Markham, the Founder and CEO of Clinlogix:
“I’m very excited to be one of the first, if not the first, CRO who is moving ahead with the rapid development and deployment of a blockchain based platform which will become an industry standard.”